Dean J. Naisbitt
University of Liverpool(GB)Drug Safety Research Unit(GB)
Publications by Year
Research Areas
Drug-Induced Adverse Reactions, Asthma and respiratory diseases, Drug-Induced Hepatotoxicity and Protection, Mast cells and histamine, Immune Cell Function and Interaction
Most-Cited Works
- → Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME(2013)1,260 cited
- → Managing the challenge of chemically reactive metabolites in drug development(2011)450 cited
- → Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial(2014)371 cited
- → Idiosyncratic Adverse Drug Reactions: Current Concepts(2013)308 cited
- → Human Leukocyte Antigen (HLA)-B*57:01-Restricted Activation of Drug-Specific T cells Provides the Immunological Basis for Flucloxacillin-Induced Liver Injury(2012)250 cited
- → Managing the challenge of drug-induced liver injury: a roadmap for the development and deployment of preclinical predictive models(2019)241 cited